You just read:

Neurologists Report Increasing Payer Pressure For Disease-Modifying Therapies, Resulting In Suboptimal Treatment For Some Patients With Multiple Sclerosis

News provided by

Spherix Global Insights

Aug 01, 2016, 11:40 ET